EP Patent

EP0337549B1 — New substituted azetidinones as anti-inflammatory and antidegenerative agents

Assigned to Merck and Co Inc · Expires 1995-10-04 · 31y expired

What this patent protects

New substituted azetidinones are found to be potent elastase inhibitors and thereby useful anti-inflammatory/antidegenerative agents.

USPTO Abstract

New substituted azetidinones are found to be potent elastase inhibitors and thereby useful anti-inflammatory/antidegenerative agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP0337549B1
Jurisdiction
EP
Classification
—
Expires
1995-10-04
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.